<VariationArchive VariationID="201571" VariationName="NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del)" VariationType="Deletion" Accession="VCV000201571" Version="14" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2016-05-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="196868" VariationID="201571">
      <GeneList>
        <Gene Symbol="SCN5A" FullName="sodium voltage-gated channel alpha subunit 5" GeneID="6331" HGNC_ID="HGNC:10593" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38548062" stop="38649687" display_start="38548062" display_stop="38649687" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38589552" stop="38691163" display_start="38589552" display_stop="38691163" Strand="-" />
          </Location>
          <OMIM>600163</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del)</Name>
      <CanonicalSPDI>NC_000003.12:38555670:GGGCTTCTGGGGCTTCT:GGGCTTCT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38555671" stop="38555679" display_start="38555671" display_stop="38555679" variantLength="9" positionVCF="38555670" referenceAlleleVCF="TGGGCTTCTG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38597162" stop="38597170" display_start="38597162" display_stop="38597170" variantLength="9" positionVCF="38597161" referenceAlleleVCF="TGGGCTTCTG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.2" sequenceAccession="NM_198056" sequenceVersion="2" change="c.4519_4527delCAGAAGCCC">
            <Expression>NM_198056.2:c.4519_4527delCAGAAGCCC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.38597170_38597178del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.38597170_38597178del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.38555679_38555687del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.38555679_38555687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008934.1" sequenceAccession="NG_008934" sequenceVersion="1" change="g.98994_99002del">
            <Expression>NG_008934.1:g.98994_99002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000335.5" sequenceAccession="NM_000335" sequenceVersion="5" change="c.4516_4524del" MANESelect="true">
            <Expression>NM_000335.5:c.4516_4524del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000326.2" sequenceAccession="NP_000326" sequenceVersion="2" change="p.Gln1506_Pro1508del">
            <Expression>NP_000326.2:p.Gln1506_Pro1508del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099404.2" sequenceAccession="NM_001099404" sequenceVersion="2" change="c.4519_4527del" MANEPlusClinical="true">
            <Expression>NM_001099404.2:c.4519_4527del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092874.1" sequenceAccession="NP_001092874" sequenceVersion="1" change="p.Gln1507_Pro1509del">
            <Expression>NP_001092874.1:p.Gln1507_Pro1509del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099405.2" sequenceAccession="NM_001099405" sequenceVersion="2" change="c.4465_4473del">
            <Expression>NM_001099405.2:c.4465_4473del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092875.1" sequenceAccession="NP_001092875" sequenceVersion="1" change="p.Gln1489_Pro1491del">
            <Expression>NP_001092875.1:p.Gln1489_Pro1491del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160160.2" sequenceAccession="NM_001160160" sequenceVersion="2" change="c.4516_4524del">
            <Expression>NM_001160160.2:c.4516_4524del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153632.1" sequenceAccession="NP_001153632" sequenceVersion="1" change="p.Gln1506_Pro1508del">
            <Expression>NP_001153632.1:p.Gln1506_Pro1508del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160161.2" sequenceAccession="NM_001160161" sequenceVersion="2" change="c.4357_4365del">
            <Expression>NM_001160161.2:c.4357_4365del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153633.1" sequenceAccession="NP_001153633" sequenceVersion="1" change="p.Gln1453_Pro1455del">
            <Expression>NP_001153633.1:p.Gln1453_Pro1455del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354701.2" sequenceAccession="NM_001354701" sequenceVersion="2" change="c.4462_4470del">
            <Expression>NM_001354701.2:c.4462_4470del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341630.1" sequenceAccession="NP_001341630" sequenceVersion="1" change="p.Gln1488_Pro1490del">
            <Expression>NP_001341630.1:p.Gln1488_Pro1490del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.3" sequenceAccession="NM_198056" sequenceVersion="3" change="c.4519_4527del">
            <Expression>NM_198056.3:c.4519_4527del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_932173.1" sequenceAccession="NP_932173" sequenceVersion="1" change="p.Gln1507_Pro1509del">
            <Expression>NP_932173.1:p.Gln1507_Pro1509del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_289" sequenceAccession="LRG_289">
            <Expression>LRG_289:g.98994_99002del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA018388" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600163.0001" DB="OMIM" />
        <XRef Type="rs" ID="397514251" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del) AND Long QT syndrome 3" Accession="RCV000009962" Version="6">
        <ClassifiedConditionList TraitSetID="2572">
          <ClassifiedCondition DB="MedGen" ID="C1859062">Long QT syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del) AND not provided" Accession="RCV000183165" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del) AND Cardiovascular phenotype" Accession="RCV002336463" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.4516_4524del (p.Gln1506_Pro1508del) AND Long QT syndrome" Accession="RCV003318368" Version="2">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-06" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2016-05-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10448858</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14654377</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15689442</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18697752</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20728579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23098067</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26022185</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26467377</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7651517</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7889574</ID>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-04-16">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2572" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2566" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 3</ElementValue>
                <XRef ID="MONDO:0011377" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT3</ElementValue>
                <XRef Type="MIM" ID="603830" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3286" />
                <XRef ID="3286" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C1859062" DB="MedGen" />
              <XRef ID="MONDO:0011377" DB="MONDO" />
              <XRef Type="MIM" ID="603830" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30183" SubmissionDate="2017-01-12" DateLastUpdated="2017-01-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600163.0001_LONG QT SYNDROME 3" title="SCN5A, 9-BP DEL, NT4661_LONG QT SYNDROME 3" />
        <ClinVarAccession Accession="SCV000030183" DateUpdated="2017-01-20" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 apparently unrelated kindreds with chromosome 3-linked LQT syndrome (LQT3; 603830), Wang et al. (1995) found deletion of 9 basepairs beginning at nucleotide 4661 of their cDNA for SCN5A. The deletion, which was detected by sequencing an aberrant SSCP conformer, resulted in deletion of lys-pro-gln (KPQ), which are 3 conserved amino acids in the cytoplasmic linker between domains III and IV of the channel protein. The 3 amino acids involved in the in-frame deletion are lys1505, pro1506, and gln1507. The effect of this mutation on membrane depolarization was studied by Bennett et al. (1995).</Attribute>
              <Citation>
                <CitationText>Wang, Q. Author's reply: link of SCN5A SNP R1193Q to long QT syndrome. (Letter) J. Med. Genet. 42: e8, 2005. Note: Electronic Article.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">7651517</ID>
              </Citation>
              <XRef DB="OMIM" ID="603830" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Clancy and Rudy (1999) developed a model representative of the behavior of the sodium channel in heart muscle cells using a single-channel-based Markov model approach. They showed that the delta-KPQ mutant form of the sodium channel stays open for too long, causing an overlarge inward current of sodium which gives rise to arrhythmia. This model view was corroborated by experiments recording actual sodium currents in cardiac muscle cells.</Attribute>
              <Citation>
                <ID Source="PubMed">10448858</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <Name>SCN5A, 9-BP DEL, NT4661</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, NT4661</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600163.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LONG QT SYNDROME 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1057955" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="887114|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000545036" DateUpdated="2024-02-20" DateCreated="2017-04-17" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14654377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18697752</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26022185</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18697752</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23098067</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26467377</ID>
          </Citation>
          <Comment>This variant is also known as delQKP1507‚Äì1509 or delKPQ. ClinVar contains an entry for this variant (Variation ID: 201571). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SCN5A function (PMID: 14654377, 18697752, 26022185). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individuals with clinical features of long QT syndrome (LQTS) (PMID: 18697752, 23098067, 26467377; Invitae). It has also been observed to segregate with disease in related individuals. This variant, c.4519_4527del, results in the deletion of 3 amino acid(s) of the SCN5A protein (p.Gln1507_Pro1509del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.38597162_38597170del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5119820" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a865312|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002635161" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14654377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18697752</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20728579</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23098067</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26467377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7889574</ID>
          </Citation>
          <Comment>The c.4519_4527delCAGAAGCCC pathogenic mutation (also known as p.Q1507_P1509del) is located in coding exon 25 of the SCN5A gene. This alteration results from an in-frame deletion of 9 nucleotides at positions 4519 to 4527. This results in the deletion 3 amino acids (QKP) at codons 1507 to 1509. This alteration (also known as p.K1505_Q1507del and &amp;Delta;KPQ) has been described in patients with long QT syndrome in addition to mixed phenotypes including cardiac conduction disease, atrioventricular (AV) block and subsequent development of dilated cardiomyopathy (DCM), and it has been observed to segregate with disease in families (Wang Q et al. Cell, 1995 Mar;80:805-11; Shi R et al. Europace. 2008 Nov;10:1329-35; Asadi M et al. Anatol J Cardiol. 2016 Mar;16:170-4). In functional in vitro analyses, this alteration has adversely affected channel function consistent with gain-of-function effects (Keller DI et al. J Mol Cell Cardiol. 2003 Dec;35:1513-21). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid region is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198056.2:c.4519_4527delCAGAAGCCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="431880" SubmissionDate="2022-08-31" DateLastUpdated="2023-03-04" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="GDXSV:237703" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000235581" DateUpdated="2023-03-04" DateCreated="2015-07-05" Type="SCV" Version="14" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Functional studies reported that this in-frame deletion results in a persistent inward sodium current (Bennett et al., 1995; Keller et al., 2003); Deletion of only the Q1507 residue results in similar functional abnormalities (Keller et al., 2003); Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of three amino acids (Glutamine-Lysine-Proline) in a non-repeat region in the linker region between DIII and DIV in the SCN5A gene (Keller et al., 2003); In silico analysis supports a deleterious effect on protein structure/function; Also known as delKPQ, deltaKPQ, delQKP, or p.Lys1505_Glu1507del (Wang et al., 1995; Tester et al., 2005; Liu et al., 2010; Postema et al., 2011); This variant is associated with the following publications: (PMID: 31535183, 21799153, 24815523, 8917568, 8620612, 20728579, 20102920, 15840476, 26022185, 7889574, 20812931, 28734073, 23098067, 10448858, 30677491, 14654377, 26467377, 18697752, 7651517)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:56545</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198056.2:c.4519_4527del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_126_20220831054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7525447" SubmissionDate="2024-01-08" DateLastUpdated="2024-01-26" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_000335.5:c.4516_4524del|Long QT syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004022097" DateUpdated="2024-01-26" DateCreated="2023-07-29" Type="SCV" Version="2" SubmitterName="Dept of Medical Biology, Uskudar University" OrgID="508813" OrganizationCategory="other" OrgAbbreviation="UU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria: PS4_Strong, PS3_Moderate, PM1, PM2, PM4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Dept of Medical Biology Variant Classification</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/azmpywta/assertion_criteria.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Ethnicity>Turkish</Ethnicity>
              <GeographicOrigin>Turkey</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000335.5:exon 26</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="397514251" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000335.5:c.4516_4524del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13704591</SubmissionName>
          <SubmissionName>SUB14116911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5119820" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1057955" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="431880" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="30183" TraitType="Disease" MappingType="Name" MappingValue="LONG QT SYNDROME 3" MappingRef="Preferred">
        <MedGen CUI="C1859062" Name="Long QT syndrome 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7525447" TraitType="Disease" MappingType="Name" MappingValue="Long QT syndrome" MappingRef="Preferred">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

